Exercise and Breast Cancer Related Lymphedema: Influence of Muscle Group and Sequence on Volume Change in Swollen and Normal Arms

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00935714
Recruitment Status : Unknown
Verified August 2009 by Hillel Yaffe Medical Center.
Recruitment status was:  Recruiting
First Posted : July 9, 2009
Last Update Posted : August 19, 2009
Tel Aviv University
Information provided by:
Hillel Yaffe Medical Center

Brief Summary:
Arm exercise influences arm volume and symptoms in breast cancer related lymphedema.

Condition or disease Intervention/treatment Phase
Breast Cancer Lymphedema Other: Exercise Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 18 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Study Start Date : August 2009
Estimated Primary Completion Date : January 2010

Arm Intervention/treatment
Active Comparator: Muscle Group
Other: Exercise
Active Comparator: Sequence
Other: Exercise

Primary Outcome Measures :
  1. Improved arm volume measurement [ Time Frame: Weekly for five weeks ]

Secondary Outcome Measures :
  1. Quality of Life [ Time Frame: Weekly for 5 weeks ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • unilateral arm lymphedema as a result of breast cancer treatment
  • completion of breast cancer treatments
  • arm lymphedema onset 3 months or more after surgery and persistent for at least 6 months
  • in the maintenance phase of lymphedema treatment

Exclusion Criteria:

  • women with recurrent cancer
  • intercurrent diseases affecting the swollen arm
  • lack of understanding of the Hebrew language

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00935714

Contact: Jillian H Bracha, BSc 972-523784551

Hillel Yaffe Medical Center Recruiting
Hadera, Israel, 38100
Sub-Investigator: Jillian Bracha, RN         
Principal Investigator: Ehud Sternberg, MD         
Sponsors and Collaborators
Hillel Yaffe Medical Center
Tel Aviv University

Responsible Party: Prof. A. Sternberg, Hillel Yaffe Medical Center Identifier: NCT00935714     History of Changes
Other Study ID Numbers: 0023-09-HYMC
First Posted: July 9, 2009    Key Record Dates
Last Update Posted: August 19, 2009
Last Verified: August 2009

Keywords provided by Hillel Yaffe Medical Center:
Breast Cancer
Breast Cancer related Lymphedema

Additional relevant MeSH terms:
Breast Neoplasms
Breast Cancer Lymphedema
Neoplasms by Site
Breast Diseases
Skin Diseases
Lymphatic Diseases
Postoperative Complications
Pathologic Processes